期刊文献+

骨髓增生异常综合征的分子生物学研究进展 被引量:5

Molecular biology for myelodysplastic syndrome:an update
原文传递
导出
摘要 骨髓增生异常综合征(myelodysplastic syndrome,MDS)的发病机制目前尚不完全清楚,可能主要与MDS的高度异质性密切相关。研究显示,致病基因异常表达、表观遗传学异常及造血干细胞的异常等分子生物学改变都与MDS的发病密切相关。因此,本文拟对近年来发现的一些与MDS发病密切相关的分子生物学特性的改变作一综述。 The pathogenesis of myelodysplastic syndrome(MDS) has not been fully clarified,it may be closely associated with the great heterogeneity in biology that characterizes this group of diseases.Recent studies have revealed that some changes in molecular biology,including abnormal expression of disease gene,abnormal epigenetics,and abnormalities of hematopoietic stem cells,were closely correlated with the pathogenesis of MDS.This article reviews the newly discovered changes of molecular and biological characteristics associated with the development of MDS.
出处 《肿瘤》 CAS CSCD 北大核心 2012年第2期137-141,共5页 Tumor
基金 国家自然科学基金面上资助项目(编号:30971277) 重庆市自然科学基金资助项目(编号:2009JJ0424)
关键词 血液肿瘤 骨髓增生异常-骨髓增生症 肿瘤标记 生物学 Hematologic neoplasms Myelodysplastic-myeloproliferative diseases Tumor markers biological
  • 相关文献

参考文献26

  • 1PELLAGATTI A,JADERSTEN M,FORSBLOM A M,et al.Lenalidomide inhibits the malignant clone and upregulates the SPRAC gene mapping to the commonly deleted region in 5q-syndrome patients[J].Proc Natl AcaedSci USA,2007,104(27):11406-11411.
  • 2BOULTWOOD J,PELLAGATTI A,CATTAN H,et al.Gene expression profiling of CD34+ cells in patients with the 5q-syndrome[J].Br J Haematol,2007,139(4):578-589.
  • 3BOULTWOOD J,FIDLER C,STRICKSON A J,et al.Narrowing and geonmic annotation of the commonly deleted region of the 5q-syndrome[J].Blood,2002,99(12):4638-4641.
  • 4DANILOVA N,SAKAMOTO K M,LIN S.Ribosomal protein S19 deficiency in zebrafish leads to developmental abnormalities and defective erythropoiesis through activation of p53 protein family[J].Blood,2008,112(13):5228-5237.
  • 5MORIMOTO K,LIN S,SAKAMOTO K.The functions of RPS19 and their relationship to Diamond-Blackfan anemia:a review[J].Mol Genet Metab,2007,90(4):358-362.
  • 6EBERT B L,PRETZ J,BOSCO J,et al.Identification of RPS14 as a 5q-syndrome gene by RNA interference screen[J].Nature,2008,451 (7176):335-339.
  • 7J(A)DERSTEN M,HELLSTR(O)M-LINDBERG E.New clues to the molecular pathogenesis of myelodysplastic syndrome[J].Exp Cell Res,2010,316(8):1390-1396.
  • 8CHLENSKI A,COHN S L.Modulation of matrix remodeling by SPARC in neoplastic progression[J].Semin Cell Dev Biol,2010,21(1):55-65.
  • 9PODHAJCER O L,BENEDETTI L G,GIROTTI M R,et al.The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the host[J].Cancer Metastasis Rev,2008,27(4):691-705.
  • 10CHEETHAM S,TANG M J,MESAK F,et al.SPRAC promoter hypermethylation in coloretal cancers can be reversed by 5-Aza-2' deoxycytidine to increase SPRAC expression and improve therapy response[J].BrJ Cancer,2008,98(11):1810-1819.

同被引文献55

  • 1龙怡,杜欣,翁建宇,林伟.老年急性白血病45例临床分析[J].临床血液学杂志,2004,17(6):313-315. 被引量:12
  • 2蒋秦燕,李晓,吴凌云,应韶旭,常春康,浦权.骨髓增生异常综合征骨髓克隆造血细胞高表达WT1[J].临床血液学杂志,2007,20(5):297-299. 被引量:5
  • 3Tefferi A, Vardiman JW. Myelodysplastic syndromes[J]. N Engl J Med,2009,361(19):1872-1885.
  • 4Mahesh S, Ginzburg Y, Verma A. Iron overload in myelodysplastic syndromes[J]. Leuk Lymphoma,2008,49 (3):427-438.
  • 5Origa R, Galanello R, Ganz T, et al. Liver iron concen- trations and urinary hepcidin in beta-thalassemia [J]. Haematologica,2007,92(5):583-588.
  • 6Tanno T, Miller JL. Iron Loading and overloading due to ineffective erythropoiesis [J]. Adv Hematol,2010,2010: 358283.
  • 7E1 Husseiny NM, Matter MM, Sabry RM, et al. Serum prohepcidin level in myelodysplasia[J]. Seand J Clin Lab Invest,2010,70(5) :343 -346.
  • 8Ganz T, Nemeth E. Hepeidin and disorders of iron metabolism[J]. Annu Rev Med,2011,62:347-360.
  • 9Nemeth E. Iron regulation and erythropoiesis[J]. Curt Opin Hematol,2008,15(3):169-175.
  • 10Tanno T, Noel P, Miller JL. Growth differentiation factor 15 in erythroid health and disease[J]. Curr Opin Hematol, 2010,17(3):184-190.

引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部